|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten
|
Luke Timmerman |
10/08/09 |
Boston
|
|
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter
|
Luke Timmerman |
03/17/09 |
Boston
|
|
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter
|
Luke Timmerman |
11/25/08 |
Boston
|
|
ProteoStasis Takes Off From $45 Launch Pad, BitWave Receives $10M Transmission, GameLogic Reckons $8M Will Do, & More Deals News
|
Rebecca Zacks |
08/25/08 |
Boston
|
|
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News
|
Rebecca Zacks |
08/20/08 |
Boston
|
|
Abiomed To Sell 2.4 Million Shares of Common Stock
|
Luke Timmerman |
08/19/08 |
Boston
|
|
Vertex Cashes Out HIV Drugs, FDA Smiles on Infinity and Frowns on Indevus, Alnylam Makes Cross-Border Investment, & More Life Sciences News
|
Rebecca Zacks |
06/05/08 |
Boston
|
|
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News
|
Rebecca Zacks |
05/07/08 |
Boston
|
|
Medicare Will Cover Abiomed Heart
|
Wade Roush |
05/02/08 |
Boston
|
|
Artificial Heart Finally Ready for Market? Abiomed’s Potential “Billion-Dollar Monopoly”
|
Rebecca Zacks |
01/23/08 |
Boston
|
|
Abiomed Device Approved
|
Rebecca Zacks |
12/19/07 |
Boston
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
